Andere Kunden interessierten sich auch für
![Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks]( "Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks")
Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks51,99 €![Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic]( "Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic")
Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic34,99 €![Public Health Lessons for Non-Vaccine Influenza Interventions]( "Public Health Lessons for Non-Vaccine Influenza Interventions")
Public Health Lessons for Non-Vaccine Influenza Interventions62,99 €![The Threat of Pandemic Influenza]( "The Threat of Pandemic Influenza")
The Threat of Pandemic Influenza73,99 €![The Domestic and International Impacts of the 2009-H1n1 Influenza a Pandemic]( "The Domestic and International Impacts of the 2009-H1n1 Influenza a Pandemic")
The Domestic and International Impacts of the 2009-H1n1 Influenza a Pandemic96,99 €![Preparing for an Influenza Pandemic]( "Preparing for an Influenza Pandemic")
Preparing for an Influenza Pandemic70,99 €![Antivirals for Pandemic Influenza]( "Antivirals for Pandemic Influenza")
Antivirals for Pandemic Influenza49,99 €
The global response to COVID-19 has demonstrated the importance of vigilance and preparedness for infectious diseases, particularly influenza. There is a need for more effective influenza vaccines and modern manufacturing technologies that are adaptable and scalable to meet demand during a pandemic. The rapid development of COVID-19 vaccines has demonstrated what is possible with extensive data sharing, researchers who have the necessary resources and novel technologies to conduct and apply their research, rolling review by regulators, and public-private partnerships. As demonstrated throughout the response to COVID-19, the process of research and development of novel vaccines can be significantly optimized when stakeholders are provided with the resources and technologies needed to support their response. Vaccine Research and Development to Advance Pandemic and Seasonal Influenza Preparedness and Response focuses on how to leverage the knowledge gained from the COVID-19 pandemic to optimize vaccine research and development (R&D) to support the prevention and control of seasonal and pandemic influenza. The committee's findings address four dimensions of vaccine R&D: (1) basic and translational science, (2) clinical science, (3) manufacturing science, and (4) regulatory science.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.